Solara Active Pharma (SOLARA) | Stock Overview & Key Data
Solara Active Pharma Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,859.95 on May 17, 2021
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Solara Active Pharma
SOLARA
|
23.00B Small-cap | 14.54% | 3.67% | 40.30% | 1.40% | 6.77% | 20.47% | 59.10% | -64.77% | 167.79% | 167.79% | 167.79% |
|
Sun Pharmaceutical
SUNPHARMA
|
3.88T Large-cap | 0.96% | -3.84% | 1.28% | 0.50% | 4.93% | 7.10% | 82.23% | 170.41% | 143.23% | 656.74% | 2,541.29% |
|
Divi's Laboratories
DIVISLAB
|
1.69T Large-cap | 1.34% | -2.25% | 8.85% | 4.11% | 4.17% | -0.43% | 85.44% | 58.15% | 496.33% | 1,610.60% | 10,946.76% |
|
Sun Pharma Advanced
SPARC
|
46.75B Small-cap | 12.49% | 39.95% | 100.62% | 67.89% | 69.61% | 34.88% | 14.54% | -3.55% | -20.47% | 148.26% | -23.02% |
|
Innova Captab
INNOVACAP
|
41.43B Small-cap | 8.95% | 10.45% | 34.08% | 34.58% | 28.37% | 3.87% | 74.08% | 74.08% | 74.08% | 74.08% | 74.08% |
|
Gujarat Themis
GUJTHEM
|
35.41B Small-cap | -4.89% | 4.00% | 38.98% | -1.40% | -12.59% | 15.75% | 76.92% | 76.92% | 76.92% | 76.92% | 76.92% |
Ownership & Short Interest
Calculate Your Solara Active Pharma Investment Returns
Long-Term Investment Performance Analysis
Solara Active Pharma stock price in Jun 2018 was ₹227.25, A ₹1,000.00 lump sum investment in Solara Active Pharma made 8 years ago would be worth approximately ₹2,645.54 today, representing a strong return of 164.55%. This translates to an annualized return (CAGR) of 12.98%.
7 Years 11 Months Investment Scenario (Jun 2018 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is SOLARA's 52-week high and low?
- In the last 52 weeks, Solara Active Pharma reached a high of ₹734.40 (on July 25, 2025) and a low of ₹422.00 (on March 30, 2026).
- What is the market cap and P/E ratio for SOLARA?
- Curious about Solara Active Pharma's size and valuation? Its market capitalization stands at 23.00B. When it comes to valuation, the P/E ratio (trailing twelve months) is 433.51, and the forward P/E (looking ahead) is 15.83.
- Does SOLARA pay dividends? If so, what's the yield?
- As for dividends, Solara Active Pharma isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Solara Active Pharma's main competitors or similar companies to consider before investing?
When looking at Solara Active Pharma, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.88T Healthcare Drug Manufacturers - Specialty & Generic 7.10% 82.23% Divi's Laboratories
DIVISLAB1.69T Healthcare Drug Manufacturers - Specialty & Generic -0.43% 85.44% Sun Pharma Advanced
SPARC46.75B Healthcare Drug Manufacturers - Specialty & Generic 34.88% 14.54% Innova Captab
INNOVACAP41.43B Healthcare Drug Manufacturers - Specialty & Generic 3.87% 74.08% Gujarat Themis
GUJTHEM35.41B Healthcare Drug Manufacturers - Specialty & Generic 15.75% 76.92% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Solara Active Pharma Sciences Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Solara Active Pharma's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 0.05%, the Debt to Equity ratio from the most recent quarter is 51.38, and its Gross Profit Margin stands at 46.53%.
- What is the recent revenue and earnings growth for SOLARA?
- Looking at Solara Active Pharma's growth, its revenue over the trailing twelve months (TTM) was INR13B. Compared to the same quarter last year (YoY), quarterly revenue grew by 16.20%, and quarterly earnings saw a YoY growth of 16.21%.
- How much of SOLARA stock is held by insiders and institutions?
- Wondering who owns Solara Active Pharma stock? Company insiders (like executives and directors) hold about 48.71% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 17.46%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.